Classys Inc 214150
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 36,250.00–37,550.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 36,750.00 / KRW 36,750.00
- Market Cap
- KRW 2.35 Tril
- Volume/Avg
- 130,617 / 295,929
Key Statistics
- Price/Earnings (Normalized)
- 32.12
- Price/Sales
- 13.15
- Dividend Yield (Trailing)
- 0.52%
- Dividend Yield (Forward)
- 0.52%
- Total Yield
- 1.16%
Company Profile
Classys Inc is engaged in the manufacturing of medical and dental instruments and supplies.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 355
- Website
- http://www.classys.co.kr
Comparables
Valuation
|
Metric
|
214150
|
145720
|
150840
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.12 | 10.96 | — |
Price/Book Value | 8.35 | 2.41 | 4.48 |
Price/Sales | 13.15 | 2.85 | 26.93 |
Price/Cash Flow | 32.39 | 9.04 | — |
Price/Earnings
214150
145720
150840
Financial Strength
|
Metric
|
214150
|
145720
|
150840
|
|---|---|---|---|
Quick Ratio | 5.33 | 0.87 | 0.49 |
Current Ratio | 6.35 | 1.41 | 0.98 |
Interest Coverage | 46.55 | 18.92 | −1.43 |
Quick Ratio
214150
145720
150840
Profitability
|
Metric
|
214150
|
145720
|
150840
|
|---|---|---|---|
Return on Assets (Normalized) | 21.05% | 13.59% | −28.93% |
Return on Equity (Normalized) | 29.26% | 23.58% | −63.47% |
Return on Invested Capital (Normalized) | 22.51% | 16.32% | −23.99% |
Return on Assets
214150
145720
150840
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Dqljvtbf | Vcvwvkc | $185.4 Bil | |
SYK
| Stryker Corp | Bmhwcyyyy | Hsb | $127.7 Bil | |
BSX
| Boston Scientific Corp | Zwtglwwzv | Rddnq | $107.6 Bil | |
MDT
| Medtronic PLC | Jpzdnsxjd | Gwhpj | $105.9 Bil | |
DXCM
| DexCom Inc | Qzhtmrqwyh | Mdmm | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Dysjnyxwgv | Gcrxnb | $52.0 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vxxjyhwhvw | Ntq | $24.6 Bil | |
ALGN
| Align Technology Inc | Bjszckxkt | Jfwncb | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Pqklfhl | Hkyxrfs | $18.7 Bil | |
PODD
| Insulet Corp | Zjgdjlsclm | Hbddm | $11.6 Bil |